Skip to main content
NewslettersWatchlist

Sirona Biochem Corp(SBM-X)
TSX Venture

Today's Change
Delayed Last Update

Sirona Biochem Corp

C/o WeWork, 595 Burrard Street
Vancouver BC V7X 1L4 CAN
P: 604-641-4466
F: 604-608-5471
https://www.sironabiochem.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.

    Key Executives

    NameTitle
    Howard VerricoCEO/Chairman of the Board/Director/Secretary
    Christopher HoptonCFO/Director
    Geraldine Deliencourt-GodefroyChief Scientific Officer/Director

    More from The Globe

    top links
    Scotia strategist updates his list of quantitatively-driven top Canadian stock picks
    Scott Barlow
    Magna shares are reeling from tariffs. And they’re worth a look
    David Berman
    Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index
    Canada Goose jackets and clothing is on display at the Harry Rosen store in Toronto on September 17, 2024.
    rob magazine
    Midstream natural gas is where it’s at for Keyera Corp. — and maybe our planet
    A Keyera Corp. facility in Alberta.
    What’s the best way to identify a blue-chip stock?
    Norman Rothery
    In a battle between two losing bank stocks, one winner emerges
    David Berman
    number cruncher
    Finding overlooked quality U.S. stocks with strong momentum
    For Number Cruncher column in Globe Investor/ROB only.
    Bullish on Transcontinental Inc.
    Monica Rizk

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2025.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.